-
Rotigotine and Bladder Function in Rat Parkinsonism
2026-08-26
This study shows that rotigotine alters lower urinary tract function in 6-hydroxydopamine-lesioned rats, with effects that depend strongly on administration route and dose. Its urodynamic findings extend Parkinson’s disease research beyond motor endpoints and support dopaminergic control of bladder overactivity as a testable therapeutic mechanism.
-
Rotigotine A3776: Reliable Cell Assay Workflows
2026-08-25
This scenario-driven guide explains how Rotigotine (SKU A3776) can support better-controlled viability, cytotoxicity, and dopaminergic signaling experiments. It connects solvent selection, concentration planning, orthogonal readouts, and preclinical dose interpretation to product specifications and a rat Parkinson’s disease study.
-
Fad2, Acsl4, and Ferroptosis in Rice Blast
2026-08-25
A 2024 study links Fad2- and Acsl4-dependent phospholipid remodeling to ferroptotic conidial death, appressorium development, and pathogenicity in Magnaporthe oryzae. Its combination of targeted lipidomics, gene deletion, oxidative perturbation, and protein-interaction analysis provides a mechanistic framework for studying lipid peroxidation in fungal disease.
-
Protoporphyrin IX: Photodynamic Research Workflows
2026-08-24
This practical guide positions Protoporphyrin IX as both a biologically interpretable heme-pathway intermediate and a photodynamic compound for controlled light-response assays. It connects photodynamic cancer diagnosis and therapy workflows with ferroptosis-focused hepatocellular carcinoma research while emphasizing formulation control, spectral validation, and mechanism-specific controls.
-
Arabidopsis Plastid DNA Breaks Across Development
2026-08-23
The reference study applies DNA end tailing and sequencing (DEtail-seq) to create a genome-wide, strand-aware map of plastid DNA breaks in Arabidopsis across development and environmental conditions. Its findings connect tissue age, ribosomal DNA vulnerability, DNA repair and replication pathways, R-loops, and reactive oxygen species to plastid genome integrity, providing a framework for studying organellar genome maintenance.
-
QRICH1, HMGB1, and HBV-Related Hepatic Fibrosis
2026-08-22
A 2025 Immunobiology study identifies QRICH1 as an important endoplasmic-reticulum-stress effector linking HBV infection to HMGB1 transcription, acetylation, translocation, and secretion. Using an rcccDNA mouse model and clinical specimens, the authors connect this pathway with hepatic fibrosis and provide a mechanistic framework for studying inflammatory liver injury.
-
Fenofibrate: Reliable Assay Workflows
2026-08-21
Learn how Fenofibrate (SKU B1943) can reduce common variability in solubility, viability, cytotoxicity, and PPARα-YAP experiments. This scenario-based guide connects practical preparation steps with receptor potency, time-dependent cellular responses, and evidence from aging-mouse liver research.
-
Latrunculin A: A Reversible Actin Probe
2026-08-20
Latrunculin A is a reversible inhibitor of actin assembly that can help separate cytoskeletal effects from mechanosensitive signaling in advanced cell assays. This article connects controlled actin perturbation with Piezo1-dependent axon regeneration research and practical experimental design.
-
Cl-Amidine for Mechanistic Stress-Response Assays
2026-08-20
Cl-Amidine trifluoroacetate salt provides a controlled PAD4 perturbation for connecting histone citrullination with immune and cancer-cell stress phenotypes. This article shows how to use it alongside ribotoxic-stress assays without confusing PAD4-dependent effects with the USP36–Snail1 survival pathway.
-
Substrate Stiffness and Dentinogenesis via FAK
2026-08-19
The reference study identifies an LAMB1–FAK–MEK1/2 signaling axis that links substrate stiffness to odontoblast-like cell extension, mineralization, and dentinogenic gene expression. Its findings provide a mechanistic framework for studying how dental biomaterials regulate reparative dentin formation through cell–material interfaces.
-
Surrogate BBB Model Corrects Lysosomal Trapping
2026-08-19
Hu and colleagues developed a high-throughput LLC-PK1-MOCK/MDR1 Transwell model that combines barrier integrity testing, P-glycoprotein transport measurements, and correction for lysosomal drug sequestration. Across 41 compounds, the platform correlated in vitro permeability with unbound brain distribution and improved interpretation of compounds with low recovery.
-
A 83-01: From TGF-β Blockade to Translation
2026-08-18
A mechanistic and strategic guide to using A 83-01 as an ALK-5 inhibitor in TGF-β pathway assays, trophoblast differentiation, EMT research, fibrosis models, and translational experimental design.
-
BAPTA for Calcium Signaling and Apoptosis
2026-08-18
BAPTA is a high-affinity calcium chelator for testing whether intracellular Ca2+ is a cause, rather than merely a consequence, of cellular injury. This guide translates a nanoplastic–cadmium apoptosis study into practical workflows for calcium signaling modulation, pathway mapping, and assay troubleshooting.
-
Perphenazine in Neuropharmacology and Host Defense
2026-08-17
Perphenazine combines dopamine D2 receptor antagonism with a broad phenothiazine receptor profile, making it useful for neuropharmacology, mitochondrial toxicity, and host-directed antibacterial assays. This guide translates published findings into practical workflows, controls, and troubleshooting decisions for reproducible laboratory research.
-
WP1066: JAK2/STAT3 Logic Beyond Oncology
2026-08-17
WP1066 is more than a cancer-pathway probe: it offers a cell-permeable way to test when JAK2/STAT3 activity sustains malignant behavior and when the same signaling axis supports regenerative macrophage function. This thought-leadership perspective connects oncology validation with bone-regeneration biology while defining practical controls, translational boundaries, and next-step experiments.